Download 4. What type of surgery is indicated?

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
4. What type of surgery is
indicated?
Operative findings:
• 3 x 2 cm ulcer of the lower gingiva with invasion
into the mandible
• 5 x 4 cm well-encapsulated firm mass located at
the submandibular triangle (level 1 to level 2 )
• Multiple pinkish-red, firm, grossly enlarged nodes
(1-2 cm) along the jugular chain (levels 2 to 4)
• 4 x 3 cm well encapsulated firm mass at the
subclavicular area
TNM Staging
T
N
M
Stage IVC
Operation done
• Wide excision of the ulcer with segmental
mandibulectomy with modified radical neck
dissection, left: the defect was reconstructed
using titanium plates.
Segmental Mandibulectomy
• removes an entire segment of the mandible,
disrupting continuity of the bone. This is
performed when tumor invades bone.
• may be performed in the setting of a
composite resection,
– resection of a segment of mandible in continuity
with a cancer of the oral cavity or oropharynx or a
primary cancer of the alveolar ridge.
http://www.expertconsultbook.com/expertconsult/ob/book.do?method=display&typ
e=bookPage&decorator=none&eid=4-u1.0-B978-1-4160-2445-3..500376&isbn=978-1-4160-2445-3
• Advantages
– Adequate margins of resection
– Excellent exposure
– Ease of exposure
• Disadvantages
• Cosmetic and functional consequences
Final histopath:
• Well differentiated squamous cell carcinoma
with metastasis to 5/20 lymph nodes, the
largest measures 2 cm with extracapsular
invasion; margins clear; with bony invasion
5. What adjuvant treatment is
required
Radiation
• Pre and post-op radiation
– Improves local/regional control in HNSCC
– within 6 weeks of surgery
– 50 to 70 Gy over 5 to 7 weeks
• Adverse reactions:
– acute: mucositis, skin erythema
– Late: fibrosis, xerostomia, altered state
Chemotherapy
• No survival advantage compared to surgery
and/or radiation
– Cisplatin, carboplatin, 5-FU
• Palliation of recurrent or unresectable disease,
combined with radiation